Urticarial vasculitis from simvastatin: What is the alternative drug?

Dermatitis

Volumn 21, Issue 4, 2010, Pages 223-224

  Bellini, Veronica ^a   Assalve, Danilo ^a   Lisi, Paolo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATENOLOL; ATORVASTATIN; FLUINDOSTATIN; MEVINOLIN; PRAVASTATIN; RAMIPRIL; ROSUVASTATIN; SIMVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHYLPREDNISOLONE;

AGED; CASE REPORT; DISEASE SEVERITY; HISTOPATHOLOGY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LETTER; MALE; PATCH TEST; PHYSICAL EXAMINATION; PRICK TEST; PRIORITY JOURNAL; SKIN BIOPSY; URTICARIA; VASCULITIS; CHEMICALLY INDUCED; CORONARY DISEASE; VASCULITIS, LEUKOCYTOCLASTIC, CUTANEOUS;

AGED; ASPIRIN; ATENOLOL; CORONARY DISEASE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; MALE; METHYLPREDNISOLONE; RAMIPRIL; SIMVASTATIN; URTICARIA; VASCULITIS, LEUKOCYTOCLASTIC, CUTANEOUS;

EID: 77955103965     PISSN: 17103568     EISSN: None     Source Type: Journal    
DOI: 10.2310/6620.2010.10030     Document Type: Letter

References (5)

1. Kapur NK, Musunuru K. Clinical efficacy and safety of statins in managing cardiovascular risk. Vasc Health Risk Manage 2008;4:341-53. (Pubitemid 351711963)
2. Josan K, Majumdar SR, McAlister FA. The efficacy and safety of intensive statin therapy: a meta-analysis of randomized trials. Can Med Assoc J 2008;178:576-84.
3. Mahley RW, Bersot TP. Drug therapy for hypercholesterolemia and dyslipidemia. In: Bruton L, Parker K, Lazo J, et al, editors. Goodman & Gilman's the pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill; 2006. p. 35.
4. Litt JZ. Simvastatin. In: Litt JZ, editor. Litt's drug eruption reference manual. New York: Informa Heathcare; 2009. p. 563.
5. Studer M, Briel M, Leimenstoll B, et al. Effect of different antilipidemic agents and diets on mortality. Arch Intern Med 2005;165:725-30.